Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2022

Open Access 09-06-2021 | Breast Cancer

Conceptualizing problems with symptoms, function, health behavior, health-seeking skills, and financial strain in breast cancer survivors using hierarchical clustering

Authors: Xiangyu Liu, Yongyi Chen, Andy SK Cheng, Yingchun Zeng, Shahid Ullah, Michael Feuerstein

Published in: Journal of Cancer Survivorship | Issue 4/2022

Login to get access

Abstract

Purpose

Determine whether a diverse set of problems experienced by breast cancer survivors (BCS) following curative treatment can be formulated into a reduced number of clusters, potentially simplifying the conceptualization of these problems.

Method

Female BCS were recruited from four cancer hospitals in China. The Chinese translation of the Cancer Survivor Profile (CSPro) was used to measure 18 common problem areas, as supported by epidemiological and phenomenological research. The Functional Assessment of Cancer Therapy–Breast (FACT-B) was used to measure quality of life, as a validation of any observed groupings. Hierarchical clustering using multiple distance criteria and aggregation methods to detect patterns of problems was used.

Results

A total of 1008 BCS (mean 46.51 years old) living in both urban and rural areas were investigated. Hierarchical cluster analysis identified two major clusters of problems. One set was classified as “functional limitations,” while the other cluster was labeled “multi-problems.” Those who fell into the multi-problem cluster experienced poorer quality of life.

Conclusion

Eighteen non-medical problems were broken down into two major clusters: (1) limitations in higher level functions required of daily life and (2) limitations in health care–seeking skills, problems with certain symptoms, unhealthy behaviors, and financial problems related to cancer. The breakdown of problem areas into these two clusters may help identify common mechanisms.

Implications for Cancer Survivors

In the future, the search for common clusters and the mechanisms for the many problems that breast cancer survivors and other cancer survivors can experience following primary treatment may improve how we help manage these problems in the future.
Literature
1.
go back to reference Klonoff-Cohen H, Polavarapu M. Existence of late-effects instruments for cancer survivors: a systematic review. PLoS One. 2020;15(2):e0229222.CrossRef Klonoff-Cohen H, Polavarapu M. Existence of late-effects instruments for cancer survivors: a systematic review. PLoS One. 2020;15(2):e0229222.CrossRef
2.
go back to reference Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes. 2020;18(1):338.CrossRef Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes. 2020;18(1):338.CrossRef
3.
go back to reference van Roij J, Fransen H, van de Poll-Franse L, Zijlstra M, Raijmakers N. Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments. Qual Life Res. 2018;27(8):1937–55.CrossRef van Roij J, Fransen H, van de Poll-Franse L, Zijlstra M, Raijmakers N. Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments. Qual Life Res. 2018;27(8):1937–55.CrossRef
4.
go back to reference Todd BL, Feuerstein M, Gehrke A, Hydeman J, Beaupin L. Identifying the unmet needs of breast cancer patients post-primary treatment: the Cancer Survivor Profile (CSPro). J Cancer Surviv. 2015;9(2):137–60 quiz 151-60.CrossRef Todd BL, Feuerstein M, Gehrke A, Hydeman J, Beaupin L. Identifying the unmet needs of breast cancer patients post-primary treatment: the Cancer Survivor Profile (CSPro). J Cancer Surviv. 2015;9(2):137–60 quiz 151-60.CrossRef
5.
go back to reference Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149.CrossRef Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149.CrossRef
6.
go back to reference Cheng ASK, Liu XY, Kwok CTT, Chung R, Zeng YC, Feuerstein M. Chinese translation of a measure of symptom burden, functional limitations, lifestyle, and health care-seeking skills in breast cancer survivors: the Cancer Survivor Profile. J Cancer Surviv. 2019;13(1):130–47.CrossRef Cheng ASK, Liu XY, Kwok CTT, Chung R, Zeng YC, Feuerstein M. Chinese translation of a measure of symptom burden, functional limitations, lifestyle, and health care-seeking skills in breast cancer survivors: the Cancer Survivor Profile. J Cancer Surviv. 2019;13(1):130–47.CrossRef
7.
go back to reference Gehrke A, Lee SS, Hilton K, Ganster B, Trupp R, McCullough C, et al. Development of the Cancer Survivor Profile-Breast Cancer (CSPro-BC) app: patient and nurse perspectives on a new navigation tool. J Cancer Surviv. 2018;12(3):291–305.CrossRef Gehrke A, Lee SS, Hilton K, Ganster B, Trupp R, McCullough C, et al. Development of the Cancer Survivor Profile-Breast Cancer (CSPro-BC) app: patient and nurse perspectives on a new navigation tool. J Cancer Surviv. 2018;12(3):291–305.CrossRef
8.
go back to reference Miaskowski C, Barsevick A, Berger A, Casagrande R, Grady PA, Jacobsen P, et al. Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst. 2017;109:4.CrossRef Miaskowski C, Barsevick A, Berger A, Casagrande R, Grady PA, Jacobsen P, et al. Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst. 2017;109:4.CrossRef
9.
go back to reference Vandenbroucke JP, Elm EV, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805–35.CrossRef Vandenbroucke JP, Elm EV, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805–35.CrossRef
10.
go back to reference Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Investig. 1993;11(3):327–36.CrossRef Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Investig. 1993;11(3):327–36.CrossRef
11.
go back to reference Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount SS, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRef Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount SS, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRef
12.
go back to reference Wan CH, Zhang DM, Yang Z, Tu X, Tang W, Feng CY, et al. Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat. 2007;106(3):413–8.CrossRef Wan CH, Zhang DM, Yang Z, Tu X, Tang W, Feng CY, et al. Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat. 2007;106(3):413–8.CrossRef
14.
go back to reference Kimes PK, Liu YF, Hayes DN, Marron JS. Statistical significance for hierarchical clustering. Biometrics. 2017;73(3):811–21.CrossRef Kimes PK, Liu YF, Hayes DN, Marron JS. Statistical significance for hierarchical clustering. Biometrics. 2017;73(3):811–21.CrossRef
15.
go back to reference Hummel M, Edelmann D, Kopp-Schneider A. Clustering of samples and variables with mixed-type data. PLoS One. 2017;12(11):e0188274.CrossRef Hummel M, Edelmann D, Kopp-Schneider A. Clustering of samples and variables with mixed-type data. PLoS One. 2017;12(11):e0188274.CrossRef
16.
go back to reference Vergara VM, Salman M, Abrol A, Espinoza FA, Calhoun VD. Determining the number of states in dynamic functional connectivity using cluster validity indexes. J Neurosci Methods. 2020;337:108651. Vergara VM, Salman M, Abrol A, Espinoza FA, Calhoun VD. Determining the number of states in dynamic functional connectivity using cluster validity indexes. J Neurosci Methods. 2020;337:108651.
17.
go back to reference de Rooij BH, Park ER, Perez GK, Rabin J, Quain KM, Dizon DS, et al. Cluster analysis demonstrates the need to individualize care for cancer survivors. Oncologist. 2018;23(12):1474–81.CrossRef de Rooij BH, Park ER, Perez GK, Rabin J, Quain KM, Dizon DS, et al. Cluster analysis demonstrates the need to individualize care for cancer survivors. Oncologist. 2018;23(12):1474–81.CrossRef
18.
go back to reference Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat. 2016;159(3):395–406.CrossRef Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat. 2016;159(3):395–406.CrossRef
Metadata
Title
Conceptualizing problems with symptoms, function, health behavior, health-seeking skills, and financial strain in breast cancer survivors using hierarchical clustering
Authors
Xiangyu Liu
Yongyi Chen
Andy SK Cheng
Yingchun Zeng
Shahid Ullah
Michael Feuerstein
Publication date
09-06-2021
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01068-w

Other articles of this Issue 4/2022

Journal of Cancer Survivorship 4/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine